Cargando…

Kinin Receptor Antagonists as Potential Neuroprotective Agents in Central Nervous System Injury

Injury to the central nervous system initiates complex physiological, cellular and molecular processes that can result in neuronal cell death. Of interest to this review is the activation of the kinin family of neuropeptides, in particular bradykinin and substance P. These neuropeptides are known to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thornton, Emma, Ziebell, Jenna M, Leonard, Anna V, Vink, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257767/ https://www.ncbi.nlm.nih.gov/pubmed/20877247 http://dx.doi.org/10.3390/molecules15096598

Ejemplares similares

Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease
por: Thornton, Emma, et al.
Publicado: (2012)

Tibial post fracture pain is reduced in kinin receptors deficient mice and blunted by kinin receptor antagonists
por: Minville, Vincent, et al.
Publicado: (2019)

Kinin-B2 Receptor Mediated Neuroprotection after NMDA Excitotoxicity Is Reversed in the Presence of Kinin-B1 Receptor Agonists
por: Martins, Antonio H., et al.
Publicado: (2012)

Kinins and Kinin Receptors in Cardiovascular and Renal Diseases
por: Girolami, Jean-Pierre, et al.
Publicado: (2021)

The Dual Role of Kinin/Kinin Receptors System in Alzheimer’s Disease
por: Ji, Bingyuan, et al.
Publicado: (2019)

Substance P and its tachykinin NK1 receptor: a novel neuroprotective target for Parkinson's disease
por: Thornton, Emma, et al.
Publicado: (2015)

Pharmacologic Targets and Prototype Therapeutics in the Kallikrein-Kinin System: Bradykinin Receptor Agonists or Antagonists
por: Sharma, J. N., et al.
Publicado: (2006)

Kinins and Their Receptors as Potential Therapeutic Targets in Retinal Pathologies
por: Othman, Rahmeh, et al.
Publicado: (2021)

Neuroprotective Effects of Kinin B2 Receptor in Organotypic Hippocampal Cultures of Middle-Aged Mice
por: Toricelli, Mariana, et al.
Publicado: (2019)

Neuroprotective effect of kinin B1 receptor activation in acute cerebral ischemia in diabetic mice
por: Desposito, Dorinne, et al.
Publicado: (2017)

Kinins and Their Receptors in Infectious Diseases
por: Dagnino, Ana Paula A., et al.
Publicado: (2020)

Neuroprotective agents effective against radiation damage of central nervous system
por: Lalkovičová, Mária
Publicado: (2022)

Kinins
por: Lewis, G. P.
Publicado: (1968)

Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19
por: van de Veerdonk, Frank L., et al.
Publicado: (2020)

NK1 Receptor Blockade Is Ineffective in Improving Outcome following a Balloon Compression Model of Spinal Cord Injury
por: Leonard, Anna Victoria, et al.
Publicado: (2014)

Kinin B1 Receptor Mediates Renal Injury and Remodeling in Hypertension
por: Basuli, Debargha, et al.
Publicado: (2022)

Kinin Hormones
por: Lande, Saul
Publicado: (1971)

Role of the kallikrein–kinin system in traumatic brain injury
por: Albert-Weissenberger, Christiane, et al.
Publicado: (2014)

Phenylalanine-Based AMPA Receptor Antagonist as the Anticonvulsant Agent with Neuroprotective Activity—In Vitro and In Vivo Studies
por: Latacz, Gniewomir, et al.
Publicado: (2022)

The effect of kinin B1 receptor on chronic itching sensitization
por: Liu, Yuying, et al.
Publicado: (2015)

Neuroprotective Activity of Thioctic Acid in Central Nervous System Lesions Consequent to Peripheral Nerve Injury
por: Tomassoni, Daniele, et al.
Publicado: (2013)

Kinin B1 receptor: a potential therapeutic target in sepsis-induced vascular hyperpermeability
por: Ruiz, Stéphanie, et al.
Publicado: (2020)

Dopamine receptor antagonists as potential therapeutic agents for ADPKD
por: Paul, Parama, et al.
Publicado: (2019)

Evolution of a neuroprotective function of central nervous system myelin
por: Yin, Xinghua, et al.
Publicado: (2006)

Connexins in the Central Nervous System: Physiological Traits and Neuroprotective Targets
por: Vicario, Nunzio, et al.
Publicado: (2017)

Neuroprotective role of galectin-1 in central nervous system pathophysiology
por: Aalinkeel, Ravikumar, et al.
Publicado: (2016)

Neuroprotective Mechanisms of Puerarin in Central Nervous System Diseases: Update
por: Yu, Chao-Chao, et al.
Publicado: (2022)

Ocular Application of the Kinin B(1) Receptor Antagonist LF22-0542 Inhibits Retinal Inflammation and Oxidative Stress in Streptozotocin-Diabetic Rats
por: Pouliot, Mylène, et al.
Publicado: (2012)

Enhanced delivery of IL-1 receptor antagonist to the central nervous system as a novel anti–transferrin receptor-IL-1RA fusion reverses neuropathic mechanical hypersensitivity
por: Webster, Carl I., et al.
Publicado: (2016)

Kinin B1 Receptor Signaling in Skin Homeostasis and Wound Healing
por: Matus, Carola E., et al.
Publicado: (2020)

Neuroprotective Role of the Ron Receptor Tyrosine Kinase Underlying Central Nervous System Inflammation in Health and Disease
por: Dey, Adwitia, et al.
Publicado: (2018)

The kallikrein-kinin system in diabetic nephropathy
por: Tomita, Hirofumi, et al.
Publicado: (2012)

Kallikrein–kinin system: is it the fountain of youth?
por: Garaffa, Giulio, et al.
Publicado: (2017)

Role of Kinins in Hypertension and Heart Failure
por: Hamid, Suhail, et al.
Publicado: (2020)

Neuroprotective Effects of Lipoxin A4 in Central Nervous System Pathologies
por: Martini, Alessandra Cadete, et al.
Publicado: (2014)

Tissue-type plasminogen activator is a neuroprotectant in the central nervous system
por: Yepes, Manuel
Publicado: (2015)

Neuroprotective Effects of Anthraquinones from Rhubarb in Central Nervous System Diseases
por: Li, Xun, et al.
Publicado: (2019)

Neuroprotective Mechanisms of Ginsenoside Rb1 in Central Nervous System Diseases
por: Gong, Liang, et al.
Publicado: (2022)

Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases
por: Shin, Jung-Won
Publicado: (2023)

Venous endothelial injury in central nervous system diseases
por: Alexander, Jonathan S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pnktruu5e821ouek2ru8jmhiof